Australia markets closed

Harvard Apparatus Regenerative Technology Inc. (HRGN)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
2.6800+0.4800 (+21.82%)
At close: 03:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
103
0
0
0
-
Cost of revenue
36
24
0
-
0
0
Gross profit
124
79
0
0
0
-
Operating expenses
Research development
1,567
3,062
1,742
1,592
2,069
-
Selling general and administrative
8,994
6,007
4,411
7,044
3,256
-
Total operating expenses
10,561
9,069
6,153
8,471
4,878
-
Operating income or loss
-10,561
-8,990
-6,153
-8,471
-4,878
-
Interest expense
-
14
9
-
-
-
Total other income/expenses net
110
-5
89
493
13
-
Income before tax
-10,451
-8,945
-6,073
-7,978
-4,865
-
Income from continuing operations
-10,451
-8,945
-6,073
-7,978
-4,865
-
Net income
-10,451
-8,945
-6,073
-7,978
-4,865
-
Net income available to common shareholders
-10,546
-9,022
-6,253
-7,978
-4,865
-
Basic EPS
-0.66
-0.67
-0.55
-0.79
-0.55
-
Diluted EPS
-0.66
-0.67
-0.55
-0.79
-0.55
-
Basic average shares
12,919
13,456
11,350
10,062
8,794
-
Diluted average shares
12,919
13,456
11,350
10,062
8,794
-